GlassScriptPhysician profile
Angela Angel
NPI 1578516654
$3,055.15
in general payments reported to CMS, 2019-2025
28 companies · $1,269 in 2025
The $1,269 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $82.24 · 2021: $395 · 2022: $543 · 2023: $268 · 2024: $194 · 2025: $1,269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,000 · Food and Beverage: $640 · Education: $90.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,000.00 |
| Food and Beverage | $640.26 |
| Education | $90.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $1,000.00 | 2025 | |
| Abbvie INC. | $549.27 | 2019-2023 | Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $198.87 | 2023-2025 | Myfembree |
| Millicent US INC | $142.73 | 2023-2025 | Intrarosa, Femlyv, Femring |
| Astellas Pharma US INC | $135.77 | 2022-2025 | Veozah |
| Myovant Sciences INC. | $128.17 | 2022 | |
| Mayne Pharma Commercial LLC | $120.40 | 2021-2023 | |
| Daiichi Sankyo INC. | $118.85 | 2021-2023 | Injectafer |
| Sage Therapeutics, LLC | $96.25 | 2021-2025 | Zurzuvae |
| Shield Therapeutics INC | $84.36 | 2024 | |
| Therapeuticsmd, INC. | $61.31 | 2019-2022 | |
| Organon LLC | $59.94 | 2022-2025 | Nexplanon |
| Pfizer INC. | $58.05 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $34.72 | 2019-2024 | Vaqta, Gardasil 9, Gardasil |
| Avion Pharmaceuticals | $28.00 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $27.71 | 2019 | |
| Axonics, INC. | $24.16 | 2023 | Bulkamid |
| Biom'Up France Sas | $24.13 | 2021 | |
| Ethicon US, LLC | $19.13 | 2021 | |
| Vertical Pharmaceuticals, LLC | $18.91 | 2019 | |
| Coopersurgical, INC. | $18.31 | 2019 | |
| Medtronic, INC. | $18.25 | 2021 | |
| Agile Therapeutics, INC. | $16.39 | 2022 | |
| Kedrion Biopharma INC. | $15.91 | 2019 | |
| Hologic Sales and Service, LLC | $15.70 | 2022 | |
| Becton, Dickinson and Company | $15.33 | 2022 | |
| Medline Industries LP | $13.45 | 2019 | |
| Minerva Surgical, INC | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Angel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.